Volatile organic compounds in breath as markers of lung cancer: A cross-sectional study

Lancet

Volumn 353, Issue 9168, 1999, Pages 1930-1933

  Phillips, Michael ^a,b,c   Gleeson, Kevin ^d   Hughes, J Michael B ^e   Greenberg, Joel ^a,b   Cataneo, Renee N ^a,b,c   Baker, Leigh ^e   McVay, W Patrick ^f  

^a MENSSANA RESEARCH INC   (United States)

^b ST VINCENT S HOSPITAL   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^e IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^f McVay Consulting Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE; ALKANE DERIVATIVE; BENZENE DERIVATIVE; MARKER; VOLATILE ORGANIC COMPOUND;

ADULT; AGED; ARTICLE; BREATHING; BRONCHOSCOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISCRIMINANT ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HISTOLOGY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 0033526615     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)07552-7     Document Type: Article

References (30)

1. Minna JD. Neoplasms of the lung. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. eds. Harrison's principles of internal medicine, 14th edn. New York: McGraw Hill, 1998.
2. Phillips M. Breath tests in medicine. Sci Am 1992; 267: 74-79.
3. Pauling L, Robinson AB, Teranishi R, Cary P. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Nat Acad Sci USA 1971; 68: 2374-76.
4. O'Neill HJ, Gordon SM, O'Neill MH, Gibbons RD, Szidon JP. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. Clin Chem 1988; 34: 1613-18.
5. Gordon SM, Szidon JP, Krotoszynski BK, Gibbons RD, O'Neill HJ. Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem 1985; 31: 1278-82.
6. Preti G, Labows JN, Kostelc JG, Aldinger S, Daniele R. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography mass spectrometry. J Chromatogr 1988; 432: 1-11.
7. Khyshiktyev BS, Khyshiktueva NA, Ivanov VN, Darenskaia SD, Novikov SV. Diagnostic value of investigating exhaled air condensate in lung cancer (in Russian). Vopr Onkol 1994; 40: 161-64.
8. Prakash UBS. Optimal bronchoscopy. J Bronchology 1994; 1: 4-62.
9. Phillips M. Method for the collection and assay of volatile organic compounds in breath. Anal Biochem 1997; 247: 272-78.
10. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. Variation in volatile organic compounds in the breath of normal humans. J Chromatograph B Biomed Sci Appl (in press).
11. Phillips M, Greenberg J, Sabas M. Alveolar gradient of pentane in normal human breath. Free Radic Res 1994; 20: 333-37.
12. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-38.
13. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994; 43 (7 suppl): 1890s-94s.
14. Knight JA. Diseases related to oxygen-derived free radicals. Ann Clin Lab Sci 1995; 25: 111-21.
15. Borek C. Molecular mechanisms in cancer induction and prevention. Environ Health Perspect 1993; 101 (suppl 3): 237-45.
16. Kneepkens CMF, Ferreira C, Lepage G, Roy CC. The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. Clin Invest Med 1992; 15: 163-86.
17. Kneepkens CMF, Lepage G, Roy CC. The potential of the hydrocarbon breath test as a measure of lipid peroxidation. Free Radic Biol Med 1994; 17: 127-60.
18. Hietanen E, Bartsch H, Bereziat JC, et al. Diet and oxidative stress in breast, colon and prostate cancer patients: a case control study. Eur J Clin Nutr 1994; 48: 575-86.
19. Weitz ZW, Birnbaum AJ, Sobotka PA, Zarling EJ, Skosey JL. High breath pentane concentrations during acute myocardial infarction. Lancet 1991; 337: 933-35.
20. Sobotka PA, Gupta DK, Lansky DM, Costanzo MR, Zarling EJ. Breath pentane is a marker of acute cardiac allograft rejection. J Heart Lung Transplant 1994; 13: 224-29.
21. Humad S, Zarling E, Clapper M, Skosey JL. Breath pentane excretion as a marker of disease activity in rheumatoid arthritis. Free Rad Res Commun 1988; 5: 101-06.
22. Olopade CO, Zakkar M, Swedler WI, Rubinstein I. Exhaled pentane levels in acute asthma. Chest 1997; 11: 862-65.
23. Crosbie SJ, Blain PG, Williams FM. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers. Hum Exp Toxicol 1997; 16: 131-37.
24. Scheller U, Zimmer T, Kargel E, Schunck WH. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4. Arch Biochem Biophys 1996; 328: 245-54.
25. Gordon SM. Identification of exposure markers in smokers' breath. J Chromatogr 1990; 511: 291-302.
26. Govert JA, Kopita JM, Matchar D, Kussin PS, Samuelson WM. Cost-effectiveness of collecting routine cytologic specimens during fiberoptic bronchoscopy for endoscopically visible lung tumour. Chest 1996;109:451-56.
27. Mak VH, Johnston ID, Hetzel MR, Grubb C. Value of washings and brushings at fibreoptic bronchoscopy in the diagnosis of lung cancer. Thorax 1990; 45: 373-76.
28. Popp W, Merkle M, Schreiber B, Rauscher H, Ritschka L, Zwick H. How much brushing is enough for the diagnosis of lung tumours? Cancer 1992; 70: 2278-80.
29. Popp W, Rauscher H, Ritschka L, Redtenbacher S, Zwick H, Dutz W. Diagnostic sensitivity of different techniques in the diagnosis of lung tumors with the flexible fiberoptic bronchoscope. Cancer 1991; 67: 72-75.
30. Brawley OW, Kramer BS. Prevention and early detection of cancer. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. eds. Harrison's principles of internal medicine, 14th edn. New York: McGraw Hill, 1998.